©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Identification of a New Acute Phase Protein (*)

(Received for publication, June 28, 1995)

Quansheng Liu Marit Nilsen-Hamilton (§)

From the Department of Biochemistry and Biophysics, Iowa State University, Ames, Iowa 50011

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

We have previously reported mouse SIP24 protein as a secreted inducible protein produced by quiescent Balb/c 3T3 cells. SIP24 can be produced in response to many factors, including serum, basic fibroblast growth factor, prostaglandin F2alpha, phorbol ester, and dexamethasone. Here we present evidence to show that SIP24 is the product of mouse 24P3 mRNA. The 24P3 cDNA was originally cloned from an SV40-transformed quiescent mouse primary kidney cell culture, and it has been classified as a new member of the lipocalin protein family. We show that the SIP24/24P3 protein and mRNA increase dramatically in mouse serum and liver during the acute phase response induced by turpentine injection. Injection of mice with dexamethasone caused a modest increase of SIP24/24P3 mRNA in the liver. Tissue distribution studies revealed that SIP24/24P3 is mainly expressed in liver during the acute phase response. SIP24/24P3 was also detected in the brain and the uterus. In mouse BNL (Balb/c normal liver) cells, the production of SIP24/24P3 is stimulated by tumor necrosis factor alpha, which is a major regulator of the expression of other acute phase proteins. From its pattern of regulation, we conclude that SIP24/24P3 is a new type 1 acute phase protein.


INTRODUCTION

The acute phase response (APR) (^1)is a complex reaction to various inflammatory or stressful stimuli such as surgery, wounding, bacterial or virus infection, or elevated levels of stressful and tissue-damaging agents. During this mammalian stress response, the plasma levels of a group of proteins change rapidly. These proteins are called the acute phase proteins (APPs; (1, 2, 3) ). Those proteins whose plasma levels increase are called positive APPs; examples include C-reactive protein, alpha(1)-acid glycoprotein (AGP), alpha(2)-macroglobulin, and haptoglobin. The plasma levels of negative APPs decrease in response to inflammation or other invasive stress; examples include retinol-binding protein and albumin. The APPs are synthesized mainly in the liver and are secreted into the bloodstream(4) . The precise functions of many APPs are still largely unknown. It is generally believed that the APPs play an anti-inflammatory role to prevent ongoing tissue damage and to return the organism to normal function. The known functions of APPs can be classified into three categories, including the maintenance of homeostasis, the transport of a variety of factors, and defense against infection(3) .

The regulation of hepatic APP production is mediated by several classes of factors(2, 3, 5) . First, the interleukin-1-type cytokines, which include interleukin 1alpha, interleukin 1beta, tumor necrosis factor alpha, and tumor necrosis factor beta, induce type-1 APPs such as human C-reactive protein and rat haptoglobin. The interleukin-1-type like cytokines also decrease the expression of type 2 APPs. Second, the interleukin 6-type cytokines, which include interleukin 6 (IL-6), interleukin 11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor induce primarily type 2 APPs such as rat alpha(2)-macroglobulin. Third, glucocorticoids are believed to play a permissive role during the APR because by themselves they cause small increases in the production of most APPs but strongly enhance the effect of cytokines on most APPs. Fourth, growth factors such as FGF, insulin, transforming growth factor beta, and hepatocyte growth factor regulate APPs in a way similar to glucocorticoids. Experimentally, the APR can be induced by injection of animals with inflammatory agents such as turpentine(1, 6) .

We have reported previously the induction, characterization, purification, and partial peptide sequencing of a superinducible protein, SIP24, produced by quiescent Balb/c 3T3 mouse fibroblast cells (7, 8, 9) . SIP24 is a 24-kDa secreted glycoprotein induced by serum, basic fibroblast growth factor (bFGF), prostaglandin F2alpha (PGF2alpha), phorbol ester, and dexamethasone. It is superinducible because it can be further induced in a synergistic manner with growth factors if the cells are pretreated with the protein synthesis inhibitor, cycloheximide. We have identified SIP24 as the protein product of the mouse 24P3 mRNA, whose cDNA was originally cloned from SV40-infected mouse kidney primary cell cultures(10) . The 24P3 protein is also a major secretory protein of cultured mouse PU5.1.8 macrophage cells which have been stimulated by lipopolysaccharide(11) .

Based on the amino acid sequence deduced from its cDNA, Flower et al.(12) identified 24P3 as a new member of the lipocalin protein family. Proteins closely related in sequence to 24P3 are rat alpha(2)-microglobulin-related protein and human neutrophil gelatinase-associated lipocalin(12, 13) . The lipocalin family is mainly composed of extracellular ligand binding proteins with high specificity for small hydrophobic molecules. Examples of lipocalin family members include alpha(1)-acid glycoprotein (AGP), alpha(2)-microglobulin, plasma retinol binding protein, and beta-lactoglobulin. Some lipocalin proteins, including AGP, alpha(2)-macroglobulin, and retinol-binding protein, are also APPs, and they can be regulated by glucocorticoids in vitro and in vivo(2, 3) . Here we present evidence to show that SIP24/24P3 is highly induced during the APR in vivo, and it is mainly expressed in liver during the APR. SIP24/24P3 is also expressed in the brain and the uterus. Moreover, the expression of SIP24/24P3 can be regulated in cultured cells by TNF-alpha which is amajor mediator of the APR. Our results also show that SIP24/24P3 is a type 1 APP.


EXPERIMENTAL PROCEDURES

Materials

Dexamethasone and cycloheximide were purchased from Sigma. For studies with cultured cells, the dexamethasone was dissolved in ethanol as a 1,000-fold concentrated stock. The dexamethasone stocks used for injection into animals were prepared from the water-soluble form of dexamethasone encapsulated in 2-hydroxypropyl-beta-cyclodextrin (Sigma). 2-Hydroxypropyl-beta-cyclodextrin dissolved in water at the same concentration as in the dexamethasone-containing solutions was used for the control (vehicle) injections. The turpentine used for inducing the APR in mice was purchased from E. E. Zimmermann (Pittsburgh, PA). Polyclonal anti-SIP24 serum was raised in a rabbit in our laboratory (9) . Two preparations of rabbit polyclonal anti-24P3 sera (376 and 377) were gifts from Dr. Lydie Meheus (Innogenetics Institute, Ghent, Belgium). A 5` segment of 24P3 cDNA was a gift from Dr. Suzanne Hraba-Renevey (Embryologie Moléculaire et Morphogénèse Institute, Geneva, Switzerland). The mouse a(1)-acid glycoprotein (mAGP) isoform 3 times cDNA from mouse strain Mus caroli was a gift from Dr. Heinz Baumann (Roswell Park Cancer Institute, Buffalo, NY). Cloned rat 18 S rRNA in plasmid pDF8 was a gift from Drs. Richard Torczynski and Harris Busch (Wadley Institutes of Molecular Biology, Dallas, TX; (14) ). Recombinant mouse IL-6 (1.0 times 10^5 units/µg) and TNF-alpha (4.2 times 10^5 units/µg) were purchased from Boehringer Mannheim Corp. TranS-label was from ICN. Nitrocellulose membranes were purchased from Micron Separations Inc. (Westboro, MA), and Zeta-Probe nylon membranes were from Bio-Rad Laboratories. Dulbecco-Vogt's modified Eagle's (DME) medium, calf serum, penicillin, and streptomycin were from Life Technologies, Inc.

Cell Culture

Stock cultures of mouse Balb/c 3T3 and BNL cells were grown in Dulbecco-Vogt's modified Eagle's (DME) medium with both 10% calf serum and 10 units/ml each of penicillin and streptomycin. The cultures were maintained at 37 °C in a humidified atmosphere of 10% CO(2) in air.

Cell Culture and Preparation of Medium Containing SIP24

Balb/c 3T3 cells or BNL cells were plated on plastic dishes in DME containing 10% calf serum and 10 units/ml penicillin/streptomycin. After the cells had reached confluency, the medium was changed to 2% calf serum. Two to three days later, the cells were treated with cycloheximide, dexamethasone, IL-6, or TNF-alpha in serum-free DME medium as described for each experiment. The media were then collected and centrifuged to remove cell debris, the supernatants were lyophilized, and the pellets were redissolved in distilled H(2)O and stored at -20 °C until use.

Western Blot Analysis

Samples of concentrated conditioned culture media and diluted serum samples were resolved by SDS-PAGE(9, 15) , and the proteins were transferred to nitrocellulose membranes (16) . The transferred proteins were detected by immunostaining using either the Stratagene picoBlue alkaline phosphatase kit to produce a blue stain or horseradish peroxidase-conjugated secondary antibody (Organon Teknika Corp., West Chester, PA) and ECL Western blotting detection reagents (Amersham) to produce a luminescent stain.

Induction of the Acute Phase Response in Mice

Turpentine or 0.9% sterile saline (5 ml/kg body weight) was injected intramuscularly into 5-week-old to 6-month-old male and female CF-1 mice. Dexamethasone or the vehicle alone (5 mg/kg body weight) were injected intraperitoneally. Twelve hours after injection, blood samples from each mouse were taken by tail-bleeding. Twenty-four hours after injection, the mice were sacrificed by cervical dislocation. Blood samples were taken immediately by heart puncture and incubated at 37 °C for 1 h. A spatula was used to detach the clots from the walls of the tube every 15 min. The samples were then spun in a microcentrifuge for 5 min at room temperature. The supernatants (sera) were collected for later Western blot analysis. From the same animal, the liver and other organs were quickly collected, frozen in liquid nitrogen, and stored at -70 °C prior to RNA extraction.

RNA Analysis

For extraction of total RNA, organs were homogenized in 4 M guanidine isothiocyanate buffer and centrifuged through CsCl(17) . Northern blot analysis was carried out by separation of 15 µg of total RNA on 0.9% agarose gel containing formaldehyde. The contents of the gel were transferred to nylon membranes and hybridized to a P-labeled 24P3 5` region cDNA probe (440 base pairs), a mAGP cDNA probe (700 base pairs), and a rat 18 S rRNA cDNA probe (750-base pair EcoRI/PstI fragment). The membranes were stripped between hybridization with the different probes. The RNA band was visualized by autoradiography. The results were quantitated by using a PhosphorImager (Molecular Dynamics). Tests of the quantitative nature of the data obtained from the PhosphorImager showed that the amount of radioactivity reported by the instrument was linear with respect to that determined by scintillation spectrometry over a range of 0 to 2 times 10^6 cpm per band.

Peptide Sequence Analysis

SIP24 was purified and sequenced as described previously(9) .

Metabolic Labeling of SIP24/24P3

BNL cells were grown to quiescence. Interleukin 6 or TNF-alpha was added at the final concentrations described for each experiment, and the cells were incubated for 24 h. The medium was then removed, and the cells were rinsed twice with Tris-buffered salts. The cells were then metabolically labeled for 4 h by incubation with 100 mCi/ml TranS-label in DME (with 10% of the normal methionine concentration), 0.2% calf serum, and the same additions as present during the previous 24-h incubation. Details of this procedure have been described(7, 8, 9, 15) . The samples of medium were resolved by SDS-PAGE, and the gels were impregnated with 2,5-diphenyloxazole and exposed to film. The relative amounts of SIP24/24P3 produced under each test condition were quantitated by densitometric analysis of the resulting fluorograms. The results from densitometry which were proportional to the relative amount of radioactive label associated with each protein band were normalized to the trichloroacetic acid-precipitable counts/min in the postnuclear supernatant of the cell population corresponding to the sample of conditioned medium. In this way, the rate of incorporation into each secreted protein was normalized to the overall rate of protein synthesis.


RESULTS

SIP24 Shares Extensive Identity with the Deduced Amino Acid Sequence of 24P3

We have previously reported the purification and partial sequencing of SIP24(9) . In those studies, four peptides from clostripain-digested SIP24 were chosen to sequence and to compare with GenBank and EMBL data bases. No identical sequence was found. The longest peptide (peptide B) showed 94% identity with mouse cyclophilin, and other peptides showed some identity with cyclophilin. From these results, SIP24 was thought to be a cyclophilin-like protein.

The sequences of seven peptides obtained from a clostripain digestion of the purified SIP24 protein were compared with the sequences found in an updated SwissProt data base. All peptide sequences except peptide B were found to share identity with the deduced amino acid sequence of 24P3 cDNA (Fig. 1). The six SIP24 peptides that are identical with 24P3 cover 25% of the complete 24P3 sequence and are spread over the entire 24P3 coding region. The 24P3 cDNA was cloned by Hraba-Renevey et al.(10) from quiescent mouse kidney primary cell cultures infected by SV40. 24P3 mRNA can also be induced by serum in 3T3 fibroblast cells as can the SIP24 protein(7, 10) . These findings suggested that SIP24 is the product of the 24P3 mRNA, and that peptide B containing the cyclophilin-like sequence came from a contaminating protein in the SIP24 preparation. As judged by the area under the peptide B peak after reverse-phase high performance liquid chromatography, the molar ratio of the cyclophilin-like peptide to the other peptides in the clostripain digests was less than 0.4 (the sequencing of this peptide did not go to completion). Although such a molar ratio could have arisen because a larger proportion of peptide B was lost during the procedure, it is also consistent with peptide B having been derived from a contaminating protein.


Figure 1: Comparison between the SIP24 and 24P3 deduced amino acid sequences. The lower horizontal line represents the 24P3 sequence. All numbers except the first and the last indicate the amino acid position on the deduced 24P3 protein sequence at which the sequences of the peptides shown for SIP24 begin. Position 1 is the first amino acid in the 24P3 sequence that includes a putative signal sequence. Identities of sequence between the SIP24 and 24P3 are indicated by a line on the 24P3 map without interruptions of the amino acid letter code. The single location in which the sequence of one of the SIP24 peptides did not match the 24P3 sequence is indicated with a letter interrupting the line representing 24P3. The mismatch was found in peptide E in which a glycine was found in the SIP24 peptide sequence in the position of a lysine in the 24P3 sequence. The sequences of peptides A, C, and D have been reported previously(9) . Peptides E, F, and G are newly identified and sequenced peptides from a clostripain digest of SIP24. The symbol ? in the sequence of peptide G indicates that the amino acid in this position was not detected as a recognizable peak.



Anti-SIP24 and Anti-24P3 Immune Sera Recognize the Same Protein

To test the hypothesis that SIP24 and 24P3 are the same protein, we performed Western blot analyses with anti-SIP24 and two preparations of anti-24P3 antisera raised against the 24P3 protein expressed in Escherichia coli. The concentrated control and SIP24-containing media were blotted with either anti-SIP24 or anti-24P3 sera. The antibodies raised against 24P3 detected the same protein band in the SIP24-enriched medium as did anti-SIP24 serum (Fig. 2). To rule out the possibility that anti-SIP24 and anti-24P3 sera recognized two different proteins of similar apparent size, a mixture of anti-SIP24 and anti-24P3 sera was also tested, and the result showed a single stained band (Fig. 2). Therefore, the results of Western blot analysis support the prediction from the analysis of SIP24-derived peptide sequences that SIP24 protein and 24P3 mRNA are derived from the same or from two very closely related genes.


Figure 2: Recognition of SIP24 by antisera raised against 24P3 by Western blot analysis. Quiescent Balb/c 3T3 cells were incubated with or without 1 mg/ml cycloheximide and 400 ng/ml dexamethasone (DEX/CHX) in serum-free DME medium for 18 h. The media were concentrated and resolved by SDS-PAGE, and the Western blots were stained with preimmune serum (PI), anti-SIP24 (alpha-SIP24), or two preparations of anti-24P3 sera (376, 377) either alone or as a 1:1 mixture. The Western blot was visualized by using the Stratagene picoBlue alkaline phosphatase kit. Arrows on the left indicate the positions of the molecular weight markers expressed in thousands, from top to bottom: bovine serum albumin (67,000), ovalbumin (45,000), carbonic anhydrase (30,000), myoglobin (18,000), and cytochrome c (12,500).



24P3 mRNA and SIP24 Protein Both Increase Dramatically during the Acute Phase Response

To test the hypothesis that SIP24/24P3 is an acute phase protein, we induced the APR in male and female mice by injection with turpentine. Twenty-four hours after injection, total RNA was extracted from mouse liver and analyzed by Northern blot. The 24P3 cDNA probe recognized a uniform band corresponding to an mRNA of about 1.0 kilobases, which was in perfect agreement with the previously reported size of 24P3 mRNA(10) . The 24P3 mRNA level was very low or undetectable in the livers of uninjected (data not shown) or of saline-injected mice, whereas the livers of both male and female mice injected with turpentine had increased levels of this mRNA (Fig. 3A). The relative amounts of 24P3 mRNA were determined after normalizing the values for band densities of 24P3 mRNA to the band densities of 18 S rRNA on the same blots. The average ratio of normalized 24P3 mRNA in the turpentine-injected mice over normalized 24P3 mRNA in the control mice was 416 ± 117 (n = 12). The membranes were also hybridized with the mAGP cDNA probe. The ratio of normalized mAGP mRNA in the livers of turpentine-injected versus saline-injected animals was calculated to be 12 ± 5 (n = 6). This result matches well the 10- to 20-fold increase in mAGP mRNA after turpentine injection which was reported by Prowse and Baumann(18) .


Figure 3: SIP24/24P3 is an acute phase protein. A, Northern blot of saline- and turpentine-injected mouse liver total RNA. Male and female mice were injected with 0.9% sterile saline (Saline) or turpentine (Turpentine). Twenty-four hours after injection, total RNAs were extracted from the livers and resolved by agarose gel electrophoresis. The resolved RNAs were transferred to nylon membranes and hybridized sequentially with P-labeled 24P3, mAGP, and rat 18 S rRNA cDNA probes. The same experiment was performed twice, and a total of 12 mice (6 male and 6 female) were treated under each condition. Numbers on the right show the positions of the 18 S and 28 S rRNA markers and the estimated molecular weight of the 24P3 mRNA. B, Western blot analysis of sera from saline- and turpentine-injected mice. The same male and female mice were used as for A. Serum samples were prepared 12 and 24 h after injection of saline or turpentine. Samples (30 µl) of 2.5% sera were resolved by SDS-PAGE and blotted against preimmune serum (PI) and anti-SIP24 serum (alpha-SIP24) as described under ``Experimental Procedures.'' A sample of SIP24-enriched cell culture medium as used in Fig. 2was included as positive control (C). Numbers on the left indicate molecular weight markers in thousands.



To determine the effect of turpentine injection on the level of SIP24/24P3 in the bloodstream, sera from saline- and turpentine-injected mice were collected 12 and 24 h after injection, and SIP24 was detected by Western blot analysis. As in the results for the Northern blots of 24P3 mRNA, SIP24 protein was undetectable in sera from saline-injected mice. However, SIP24 was detected in sera from turpentine-injected mice. Sera collected at both 12 and 24 h after injection of turpentine had elevated levels of SIP24 (Fig. 3B). There was no observable difference between the sexes in the extent to which SIP24 was elevated. Thus, as for 24P3 mRNA in liver, turpentine treatment elevated the SIP24 protein level in the bloodstream.

Dexamethasone Induces a Modest Increase in 24P3 mRNA in Liver

Because dexamethasone induces SIP24/24P3 in cultured Balb/c 3T3 cells and regulates the APR in vivo, we also examined the 24P3 mRNA and SIP24 protein levels in dexamethasone-injected mouse livers and sera by Northern and Western blot analyses, respectively. Twenty-four hours after injection of the vehicle, 24P3 mRNA was very low or undetectable in the injected control mouse livers. By comparison, 24 h after the injection of dexamethasone, there was a modest but obvious elevation in the liver 24P3 mRNA level (Fig. 4). The increase in 24P3 mRNA in the livers of dexamethasone-injected mice compared with control mice was 8 ± 3-fold (n = 12). Like turpentine, dexamethasone had a similar effect in male and female mice. Northern blot analysis of mAGP mRNA showed the expected marginal increase (1.25 ± 0.20-fold over control; n = 6) of mAGP mRNA after dexamethasone treatment. Unlike its rat counterpart, mouse AGP is induced only about 1.5-fold after glucocorticoid treatment(18) . The SIP24 protein could not be detected in the sera from either vehicle- or dexamethasone-injected mice by Western blot analysis (data not shown).


Figure 4: Northern blot analysis of total RNA isolated from the livers of vehicle- and dexamethasone-injected mice. Male and female mice were injected with 2-hydroxypropyl-beta-cyclodextrin (C) or dexamethasone in 2-hydroxypropyl-beta-cyclodextrin (DEX). Twenty-four hours after injection, total liver RNAs were extracted and resolved by agarose gel electrophoresis. The RNAs were then transferred to a nylon membrane and hybridized sequentially with P-labeled 24P3, mAGP, and rat 18 S rRNA probes. The same experiment was performed twice, and a total of 12 mice (6 male and 6 female) were used for each condition.



SIP24/24P3 Is Mainly Expressed in Liver

The tissue distribution of 24P3 mRNA was determined by Northern blot analysis. Twenty-four hours after saline or turpentine injection, total RNAs from liver, heart, kidney, lung, brain, skeletal muscle, and uterus were extracted and analyzed. As shown in Fig. 5, 24P3 mRNA was almost undetectable in all tissues from saline-injected mice. Of the tissues from turpentine-treated mice, the liver showed an obvious elevation in 24P3 mRNA. The 24P3 mRNA was not detected in samples from the heart, kidney, lung, and muscle of turpentine-injected mice. However, 24P3 mRNA was detected in the brain and uterus, although its level of expression in these tissues was much lower than in liver. When 24P3 mRNA levels from turpentine-injected mice were compared in these tissues after being normalized to the levels of 18 S RNA, the relative ratios were 1.00 ± 0.96, 0.01 ± 0.00, and 0.19 ± 0.00 (n = 3) in liver, brain, and uterus, respectively. Thus, it seems that SIP24/24P3 is mainly expressed in liver during the APR.


Figure 5: Tissue distribution of 24P3 mRNA in saline- and turpentine-injected animals. Twenty-four hours after injection of saline(-) or turpentine (+), total RNAs were extracted from different tissues and resolved by agarose gel electrophoresis. Three different mice (one male and two females) were used as sources of the tissues. The RNAs were transferred to nylon membranes and hybridized with P-labeled 24P3 and rat 18 S rRNA probes. The figure shows representative results from one of each of the tissues.



SIP24/24P3 Expression during Pregnancy

The reproductive system has been reported to express a number of APPs during pregnancy, including rat ceruloplasmin, transferrin, retinol-binding protein, alpha(2)-macroglobulin, and others(4) . The expression of SIP24/24P3 during mouse pregnancy was examined by Northern blot analysis. SIP24/24P3 message was found in the liver and uterus, but not in the placenta or fetus of day 11 pregnant mice (Fig. 6). The proportion of SIP24/24P3 mRNA was about the same in the uteri and livers of five midpregnant (day 11) mice.


Figure 6: 24P3 mRNA expression during pregnancy. Total RNAs from the maternal liver, uterus, placentas, and fetuses of day 11 midgestation female mice were extracted and hybridized with P-labeled 24P3 and rat 18 S rRNA probes.



Interleukin 6 and Tumor Necrosis Factor alpha Induce SIP24/24P3

We used BNL cells, a normal liver cell line, to test the cellular responses of SIP24 production to treatment with either of two major APR regulating factors. Quiescent BNL cells were treated with IL-6, TNF-alpha, and combinations of both for 24 h and then metabolically labeled for 4 h. The media containing methionine-labeled proteins were analyzed for relative rates of SIP24 synthesis as described under ``Experimental Procedures.'' The results are shown in Fig. 7A and Table 1. Interleukin 6 had little or no effect on SIP24 production by BNL cells, whereas TNF-alpha induced SIP24. The combination of 100 units/ml IL-6 and 1 ng/ml TNF-alpha treatment resulted in twice the increase in SIP24 as obtained with TNF-alpha treatment alone. Thus, IL-6 and TNF-alpha acted synergistically to increase SIP24 production by BNL cells. Western blot analysis was performed in parallel to confirm the identification of the SIP24/24P3 protein produced by BNL cells. As shown in Fig. 7B, anti-SIP24 serum detected SIP24/24P3 in medium from TNF-alpha-treated BNL cells, but not from IL-6-treated cells.


Figure 7: Regulation by cytokines of SIP24 expression in BNL cells. A, regulation by IL-6 and TNF-alpha of SIP24 synthesis and secretion. Quiescent BNL cells were incubated for 24 h with IL-6, TNF-alpha, and the combination of both factors. The culture media containing radiolabeled secreted proteins were resolved by SDS-PAGE and analyzed by fluorography as described under ``Experimental Procedures.'' The concentrations used of IL-6 (10-1000 units/ml) and of TNF-alpha (0.1 to 10 ng/ml) are shown for each lane. Numbers on the left show the positions of the proteins used as molecular weight markers with their molecular weights expressed in thousands. B, Western blot analysis of secreted SIP24. Quiescent BNL cells were incubated for 24 h with IL-6 and TNF-alpha in serum-free DME medium. The culture media were collected, centrifuged, lyophilized, and redissolved in distilled H(2)O to 1/10 of the original volume. The concentrated media were resolved by SDS-PAGE, and the Western blots were stained with preimmune serum (PI) or anti-SIP24 (alpha-SIP24). The same SIP24-enriched medium as used in Fig. 2was included as positive control (DEX/CHX). Numbers on the left indicate the positions of the molecular weight markers in thousands.






DISCUSSION

We have shown that 24P3 mRNA encodes a protein that is identical in all known aspects with SIP24. Thus, we propose that SIP24 and the protein encoded by the 24P3 mRNA are the same protein. We base our conclusion on the following structural evidence. First, the derived amino acid sequence of 24P3 has 200 amino acid residues with a putative signal peptide of 15 N-terminal hydrophobic residues, and its calculated M(r) = 22,800(10) , whereas SIP24 is secreted, has approximately 180 amino acid residues, and its estimated M(r) = 21,000 excluding the polysaccharide moiety (9) . Second, six different peptides derived from SIP24 showed identity with the 24P3 sequence. This identity covers the length of the protein. Third, the deduced 24P3 protein sequence has a potential N-glycosylation site(10) , and SIP24 is N-glycosylated(9) . Fourth, antiserum raised against SIP24 purified from 3T3 cells recognizes the same protein as do antisera raised against the 24P3 protein which had been expressed in and purified from E. coli. Fifth, probes for 24P3 mRNA and SIP24 protein detected an mRNA and a protein that were regulated in the same way in vivo. Based on this information, which showed that SIP24 and the 24P3-encoded protein are structurally and immunologically related and are regulated identically in vivo and in cultured cells, we conclude that the 24P3 mRNA encodes the SIP24 protein. Thus, we refer to this protein as SIP24/24P3.

Our results of turpentine and dexamethasone injection experiments have clearly shown that SIP24/24P3 is induced in the liver in a manner indicative of a positive APP. Because SIP24/24P3 is expressed at about the same levels in both males and females it is unlikely that sex hormones play a major role in regulating its expression. By comparison, the related lipocalin and APP rat alpha(2)-microglobulin is synthesized only in male liver(19) .

The results of our tissue distribution studies show that SIP24/24P3 is primarily expressed in liver during the APR. However, it is also expressed at lower levels in the brain and uterus during the APR. As reviewed by Aldred et al.(4) , the liver is not the only site of APP expression, even though it is the most important one in terms of magnitude of production. For example, the brain is an organ for which the extracellular compartment is separated by the blood-brain barrier from the main vascular/extravascular body compartment. So, it may be desirable for the brain to synthesize its own APPs when needed. The levels of messenger RNAs encoding several APPs are altered in the brains of various species during the APR. These proteins include rat transferrin, transthyretin, ceruloplasmin, and retinol-binding protein (4) .

SIP24/24P3 was also found expressed in the pregnant uterus in the unstressed animal. Besides liver, several APPs are also expressed in the tissues comprising the interface between the maternal and fetal body compartment in the pregnant animal; such tissues include uterus, placenta, and yolk sac(4) . Extensive tissue remodelling takes place during pregnancy with the constantly changing interaction between the fetus and the tissues of the maternal reproductive tract. The APPs may be needed to control the extent of tissue damage during pregnancy.

Although SIP24/24P3 mRNA was induced in mouse kidney primary cell culture after SV40 infection(10) , we did not detect any SIP24/24P3 mRNA expressed in kidney in either saline- or turpentine-treated mice. There are several possible explanations for these observations: 1) SIP24/24P3 mRNA may be expressed in the kidney at a level below the sensitivity of our assays; 2) conditions in vivo are different from those to which cultured cells are subjected; or 3) different factors may be required to induce SIP24/24P3 in nonparenchymal tissues such as the kidney. It has been reported that hepatic nonparenchymal cells produced IL-6 in response to intraperitoneal endotoxin (lipopolysaccharide) but not in response to intramuscular turpentine injection(20) .

The regulation of APP expression is extremely complex with many regulatory humoral factors being involved(2, 3, 5, 20, 21) . The regulation of SIP24/24P3 seems to be no exception. In Balb/c 3T3 cells, we have previously shown that SIP24/24P3 can be induced by serum, bFGF, epidermal growth factor, prostaglandin F2alpha, and phorbol 12-myristate 13-acetate(7, 8, 9) . Here we have shown that the two major APR regulating factors, IL-6 and TNF-alpha, differently regulate SIP24/24P3 expression in BNL cells. BNL cells are a Balb/c normal liver cell line that has been used to study the regulation of the APP, rabbit serum amyloid A protein gene(22) . The ability of SIP24/24P3 to be induced by TNF-alpha indicates that it is a type 1 APP(2) .

When the magnitudes of SIP24/24P3 induction after turpentine and dexamethasone injection are compared, it is clear that glucocorticoids cannot account for the entire increase in SIP24/24P3 during the APR. As for many other APPs, the interplay among various inducing factors may be necessary to achieve maximum induction of SIP24/24P3 in vivo and in cultured cells(2, 3, 5) . This possibility and the underlying mechanism of SIP24/24P3 regulation are currently under investigation in our laboratory.

Our current knowledge of the structure and regulation of SIP24/24P3 provides several clues relating to its possible function. Based upon the fact that SIP24/24P3 protein is produced both upon viral infection and lipopolysaccharide induction in cultured cells, Meheus et al.(11) have suggested that SIP24/24P3 could play a role in the defense mechanism against infection. Our identification of SIP24/24P3 as an APP suggests that it may be involved in homeostasis and have an anti-inflammatory role. A number of factors that induce SIP24/24P3, including bFGF, epidermal growth factor, and dexamethasone, also have been shown to have effects on cultured cells which would be anti-inflammatory in vivo(2, 23) . We have also shown that the tumor promoter 12-O-tetradecanoylphorbol-13-acetate induces SIP24/24P3. 12-O-Tetradecanoylphorbol-13-acetate activates protein kinase C, which induces specific acute phase responses(2, 24) .

The identification of SIP24/24P3 as a member of the lipocalin protein family suggests that SIP24/24P3 might be a binding protein for small hydrophobic molecule(s). We have reported that PGF2alpha also induces SIP24 production in 3T3 cells(7) . This prostaglandin is a mitogen for 3T3 cells(25) . Many prostaglandins, including PGF2alpha, are released as a result of increased metabolism of arachidonic acid during the APR(2) . Prostaglandins are also produced at different rates throughout pregnancy(26) . So, it is possible that the level of SIP24/24P3 is regulated during the APR and in pregnancy in response to released PGF2alpha. We speculate that SIP24/24P3 may have an anti-inflammatory role and that this role might involve the ability of SIP24/24P3 to bind a prostaglandin-like molecule.


FOOTNOTES

*
This is Journal Paper J-16227 of the Iowa Agriculture and Home Economics Experiment Station, Ames, IA, Project No. 3096. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence should be addressed: 3206 Molecular Biology Bldg., Dept. of Biochemistry and Biophysics, Iowa State University, Ames, IA 50011-3260. Tel.: 515-294-9996; Fax: 515-294-2244; MNH{at}molebio.iastate.edu.

(^1)
The abbreviations used are: APR, acute phase response; APP, acute phase protein; AGP, alpha(1)-acid glycoprotein; mAGP, mouse AGP; FGF, fibroblast growth factor; bFGF, basic FGF; PGF2alpha, prostaglandin F2alpha; TNF-alpha, tumor necrosis factor alpha; IL, interleukin; DME medium, Dulbecco's modified Eagle's medium; PAGE, polyacrylamide gel electrophoresis.


ACKNOWLEDGEMENTS

We thank Dr. Lydie Meheus for anti-24P3 sera, Dr. Suzanne Hraba-Renevey for the 24P3 cDNA, Dr. Heinz Baumann for mAGP cDNA, and Drs. Richard Torczynski and Harris Busch for the cloned rat 18 S rRNA.


REFERENCES

  1. Schreiber, G., and Howlett, G. (1983) in Plasma Protein Secretion by the Liver (Glaumann, H., Peters, T., Jr., and Redman, C., eds) pp. 423-449, Academic Press, Inc., London
  2. Baumann, H., and Gauldie, J. (1994) Immunol. Today 15,74-80 [CrossRef][Medline] [Order article via Infotrieve]
  3. Raynes, J. G. (1994) Biochem. Soc. Trans. 22,69-73 [Medline] [Order article via Infotrieve]
  4. Aldred, A. R., Southwell, B., and Schreiber, G. (1992) Folia Histochem. Cytobiol. 30,223-232 [Medline] [Order article via Infotrieve]
  5. Gauldie, J., Richards, C., and Baumann, H. (1992) Res. Immunol. 143,755-759 [Medline] [Order article via Infotrieve]
  6. Bauer, J., Birmelin, M., Northoff, G.-H., Northemann, W., Tran-Thi, T., Ueberberg, H., Decker, K., and Heinrich, P. C. (1984) FEBS Lett. 177,89-94 [CrossRef][Medline] [Order article via Infotrieve]
  7. Nilsen-Hamilton, M., Hamilton, R. T., and Adams, G. A. (1982) Biochem. Biophys. Res. Commun. 108,158-166 [Medline] [Order article via Infotrieve]
  8. Hamilton, R. T., Nilsen-Hamilton, M., and Adams, G. (1985) J. Cell. Physiol. 123,201-208 [Medline] [Order article via Infotrieve]
  9. Davis, T. R., Tabatabai, L., Bruns, K., Hamilton, R. T., and Nilsen-Hamilton, M. (1991) Biochim. Biophys. Acta 1095,145-152 [Medline] [Order article via Infotrieve]
  10. Hraba-Renevey, S., Türler, H., Kress, M., Salomon, C., and Weil, R. (1989) Oncogene 4,601-608 [Medline] [Order article via Infotrieve]
  11. Meheus, L. A., Fransen, L. M., Raymackers, J. G., Blockx, H. A., Van Beeumen, J. J., Van Bun, S. M., and Van De Voorde, A. (1993) J. Immunol. 151,1535-1547 [Abstract/Free Full Text]
  12. Flower, D. R., North, A. C. T., and Attwood, T. K. (1991) Biochem. Biophys. Res. Commun. 180,69-74 [Medline] [Order article via Infotrieve]
  13. Kjeldsen, L., Johnsen, A. H., Sengeløv, H., and Borregaard, N. (1993) J. Biol. Chem. 268,10425-10432 [Abstract/Free Full Text]
  14. Fuke, M., Dennis, K. J., and Busch, H. (1981) Mol. & Gen. Genet. 182,25-30
  15. Nilsen-Hamilton, M., and Hamilton, R. T. (1987) Methods Enzymol. 147,427-444 [Medline] [Order article via Infotrieve]
  16. Burnette, W. N. (1981) Anal. Biochem. 112,195-203 [Medline] [Order article via Infotrieve]
  17. Davis, L. G., Dibner, M. D., and Buttery, J. F. (1986) Basic Methods in Molecular Biology , pp. 130-135, Elsevier Science Publishing Co., New York
  18. Prowse, K. R., and Baumann, H. (1990) J. Biol. Chem. 265,10201-10209 [Abstract/Free Full Text]
  19. Dolan, K. P., Unterman, R., McLaughlin, M., Nakhasi, H. L., Lynch, K. R., and Feigelson, P. (1982) J. Biol. Chem. 257,13527-13534 [Free Full Text]
  20. Kushner, I. (1993) Perspect. Biol. Med. 36,611-622 [Medline] [Order article via Infotrieve]
  21. Akira, S., and Kishimoto, T. (1992) Immunol. Rev. 127,25-50 [Medline] [Order article via Infotrieve]
  22. Ray, B. K., and Ray, A. (1993) Biochem. Biophys. Res. Commun. 193,1159-1167 [CrossRef][Medline] [Order article via Infotrieve]
  23. Circolo, A., Pierce, G. F., Katz, Y., and Strunk, R. C. (1990) J. Biol. Chem. 265,5066-5071 [Abstract/Free Full Text]
  24. Baumann, H., Isseroff, H., Latimer, J. J., and Jahreis, G. P. (1988) J. Biol. Chem. 263,17390-17396 [Abstract/Free Full Text]
  25. De Asua, L. J., Carr, B., Clingan, D., and Rudland, P. (1977) Nature 265,450-452 [Medline] [Order article via Infotrieve]
  26. Embry, M. P. (1981) Br. Med. J. 283,1563-1570 [Medline] [Order article via Infotrieve]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.